Skip to content
The Scottsdale Joint Guide
Joint biology, translated without the sales fog

The Scottsdale Joint Guide

Get straight answers about joint soreness

Start with the question closest to your concern today. Each answer gives you a practical next step.

You can take the same question to a doctor or clinic. You won't need to learn medical terms before the visit.

What can I do at home for a sore joint?

Do less of the movement that brought on soreness, but keep moving gently when it feels safe. Notice whether warmth, a cold pack, or a shorter activity gives you relief.

How does regenerative medicine work?

Regenerative medicine covers clinic care made with your blood or material taken from the body. One choice is platelet-rich plasma, made by spinning blood to gather more of its clotting pieces.

What happens at a joint consultation?

A clinician reviews your health, examines the joint, and discusses available choices. Bring medicine names, old X-rays, and a note about what you can't do comfortably.

When does a sore joint need prompt care?

Strong joint heat, heavy swelling, fever, or sudden weakness calls for quick medical care. Don't wait for a planned visit if you suddenly can't stand on the sore leg.

Does regenerative therapy work for knees?

Regenerative therapy means clinic care made from blood or other body material, and studies have found mixed relief. Some people felt less knee soreness, while others noticed little change, so no one can promise your result.

What should I bring to a joint visit?

Take every medicine name, older X-rays, and a short note about past care. Add one activity you miss now, so the visit stays focused on your needs.

Sources

  1. Arnold Caplan, who NAMED mesenchymal stem cells more than 25 years earlier, argued in Stem Cells Translational Medicine that the name should be changed. His stated reason is exactly the marketing problem: because MSCs are called 'stem cells', patients infer they will receive direct medical benefit, imagining the cells will differentiate into regenerating tissue-producing cells - and hundreds of clinics and trials now use human MSCs with very few focusing on the in vitro multipotential capacities the name refers to.

    Caplan AI, et al. — Mesenchymal Stem Cells: Time to Change the Name!. Stem cells translational medicine, 2017. DOI: 10.1002/sctm.17-0051.

  2. A concise review of mesenchymal stem cells for functional cartilage tissue engineering sets out the underlying problem: articular cartilage is avascular and has very limited intrinsic repair capacity, which is precisely why engineered and cell-based approaches are being pursued - and why building tissue that matches native articular cartilage in composition and mechanical function remains an unsolved engineering problem rather than a delivered clinical product.

    Tan AR, et al. — Concise Review: Mesenchymal Stem Cells for Functional Cartilage Tissue Engineering: Taking Cues from Chondrocyte-Based Constructs.. Stem cells translational medicine, 2017. DOI: 10.1002/sctm.16-0271.

  3. A 2026 systematic review and meta-analysis of 28 randomized trials of intra-articular mesenchymal stem cell-based therapies in knee OA found significant improvements in several pain and function measures (delta-VAS MD -1.67; KOOS pain MD 15.37) but NO significant difference in WOMAC, KOOS quality of life or the Lequesne index, and MRI-based WORMS scores were non-significant - indicating no consistent structural benefit. Its own conclusion: these therapies serve a primarily SYMPTOM-modifying rather than STRUCTURE-modifying role, with higher frequencies of local reactions to weigh against the symptomatic benefit.

    Awad G, et al. — Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.. Clinical rheumatology, 2026. DOI: 10.1007/s10067-026-08042-w.

  4. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

    Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

  5. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

    US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.

  6. The AAOS third-edition clinical practice guideline for non-arthroplasty management of knee osteoarthritis is the orthopedic profession's own GRADE-style appraisal of the same options a regenerative clinic sells; it is the benchmark against which any 'regenerative' claim on this topic should be read, and it rates the strongest support for exercise, weight loss and self-management rather than for injectables.

    Brophy RH, et al. — AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.. The Journal of the American Academy of Orthopaedic Surgeons, 2022. DOI: 10.5435/JAAOS-D-21-01233.

See what may come next if soreness doesn't settle

QC Kinetix offers regenerative treatments, meaning non-surgical care made with your blood near the sore joint. Its medical providers, the clinic staff who examine joints and discuss care, review whether an available choice may fit.

One choice is platelet-rich plasma, made by spinning blood to gather more of its clotting pieces. You can ask about possible relief, cost, risk, and when you'll know whether it helped.

Book a free consultation